Annabel Samimy analyst STIFEL

Currently out of the existing stock ratings of Annabel Samimy, 243 are a BUY (86.79%), 37 are a HOLD (13.21%).

Annabel Samimy

Work Performance Price Targets & Ratings Chart

Analyst Annabel Samimy, currently employed at STIFEL, carries an average stock price target met ratio of 47.65% that have a potential upside of 41.23% achieved within 341 days.

Annabel Samimy’s has documented 516 price targets and ratings displayed on 39 stocks. The coverage is on Healthcare, Industrials, Technology sectors.

Most recent stock forecast was given on LGND, Ligand Pharmaceuticals at 08-Jul-2026.

Wall Street Analyst Annabel Samimy

Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for EOLS (EVOLUS) at 1/28/2019. The price target of $27 was fulfilled within 10 days with a profit of $12.01 (80.12%) receiving and performance score of 80.12.

Average potential price target upside

AERI Aerie Pharmaceuticals AGN Allergan plc ANGN Angion Biomedica Corp CALT Calliditas Therapeutics CARA Cara Therapeutic ENDP Endo International PLC EOLS Evolus EVFM Evofem Biosciences FGEN FibroGen HZNP Horizon Pharma PLC JAZZ Jazz Pharmaceuticals PLC MNK Mallinckrodt plc PRGO Perrigo Company PLC RDUS Schnitzer Steel Industries RETA Reata Pharmaceuticals RVNC Revance The TXMD TherapeuticsMD APLS Apellis Pharmaceuticals BHC Bausch Health Companies CLSD Clearside Biomedical SBBP Strongbridge Biopharma plc SUPN Supernus Pharmaceuticals ISEE IVERIC bio RXDX Prometheus Biosciences ZGNX Zogenix PHAS PhaseBio Pharmaceuticals VKTX Viking Therapeutics RANI Rani Therapeutics Holdings IVA Inventiva Sa RGNX Regenxbio TRVI Trevi Therapeutics LGND Ligand Pharmaceuticals PHAT Phathom Pharmaceuticals AER AerCap Holdings NV CLS Celestica GPCR Structure Therapeutics American Depositary Shares KMDA Kamada MLYS Mineralys Therapeutics, Common Stock OCS Oculis Holding AG Ordinary shares

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Show more analysts

Please expand the browser size to see the chart

Which stock is Annabel Samimy is most bullish on?

Potential upside of $37.4 has been obtained for LGND (LIGAND PHARMACEUTICALS)

Which stock is Annabel Samimy is most reserved on?

Potential downside of $37.06 has been obtained for OCS (OCULIS HOLDING AG ORDINARY SHARES)

What Year was the first public recommendation made by Annabel Samimy?

On 2009

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?